# Effect of Minocycline & Amoxicillin on Antibiotic Resistant Bacteria and Indigenous Microbiotas

> **NCT02030912** · PHASE4 · COMPLETED · sponsor: **Helperby Therapeutics Ltd** · enrollment: 42 (actual)

## Conditions studied

- Antibiotic Resistant Bacteria

## Interventions

- **DRUG:** 3 doses of amoxicillin daily for 7 days
- **DRUG:** 2 doses of minocycline daily for five days
- **OTHER:** 2 doses of placebo daily for five days

## Key facts

- **NCT ID:** NCT02030912
- **Lead sponsor:** Helperby Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030912, "Effect of Minocycline & Amoxicillin on Antibiotic Resistant Bacteria and Indigenous Microbiotas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02030912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*